Found 7 matching trials
Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. PHASE2 The recognized manifestations of HHT are all due to abnormalities in vascul...
Show More Learn More & Join Trial
Newly-diagnosed Pediatric T-cell ALL Protocol PHASE2 This is a prospective, multicenter study conducted within the Chinese Child...
Show More Location
Anhui Medical University Second Affiliated Hospital
Learn More & Join Trial
Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML N/A The aim of this study is to reveal the influence of gene mutations on the t...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML PHASE1 The purpose of this study is to assess the safety, pharmacokinetic profile ...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Pomalidomide for the Treatment of Bleeding in HHT PHASE2 This is a Phase II placebo-controlled double-blind study of pomalidomide in...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy PHASE2 This is a phase II/III, multicenter, randomized, three-arm, open-label, par...
Show More Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy PHASE2 This is a phase II/III, multicenter, randomized, three-arm, open-label, par...
Show More Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Zhejiang University
Learn More & Join Trial